2024 annual financial data
Black Diamond Therapeutics 2024 Operating income growth
Direct answer
Operating income growth was 8.88%.
Operating income was -78,781,000 USD and net income was -69,676,000 USD.
Operating cash flow was -62,303,000 USD.
Get free Black Diamond Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -78,781,000 USD
- Net income
- -69,676,000 USD
- Operating cash flow
- -62,303,000 USD